Publications by authors named "Shavon Rochester"
Article Synopsis
- Targeted cancer drugs (TCDs) have significantly changed cancer treatment, but their effectiveness and costs for patients can vary widely.
- A study analyzed 8,524 patients using oral TCDs from 2012-2020 to examine the relationship between the net health benefit (NHB) and both the uptake and spending of these drugs.
- Findings showed that TCDs with higher NHB scores were prescribed more often, and there was a strong correlation between total spending and NHB, while many patients faced little to no out-of-pocket costs.
Purpose: To develop an electronic health record (EHR)-based clinical decision support (CDS) tool to promote guideline-recommended cancer risk management among patients with Lynch syndrome (LS), an inherited cancer syndrome that confers an increased risk of colorectal and other cancer types.
Materials And Methods: We conducted a cross-sectional study to determine the baseline prevalence and predictors of guideline-recommended colonic surveillance and annual genetics program visits among patients with LS. Multivariable log-binomial regressions estimated prevalence ratios (PRs) of cancer risk management adherence by baseline sociodemographic and clinical characteristics.